Robbins Farley’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.9M Sell
4,007
-10
-0.2% -$5.03K 0.84% 46
2025
Q4
$1.88M Sell
4,017
-1,217
-23% -$565K 0.85% 45
2025
Q3
$2.23M Sell
5,234
-632
-11% -$245K 0.93% 42
2025
Q2
$2.25M Sell
5,866
-61
-1% -$22K 1.05% 38
2025
Q1
$2.05M Buy
5,927
+987
+20% +$317K 1.09% 42
2024
Q4
$1.48M Buy
4,940
+234
+5% +$81.8K 0.71% 49
2024
Q3
$1.91M Sell
4,706
-734
-13% -$269K 0.96% 43
2024
Q2
$1.75M Buy
5,440
+256
+5% +$83.2K 0.93% 45
2024
Q1
$1.73M Sell
5,184
-311
-6% -$95K 0.91% 46
2023
Q4
$1.49M Buy
5,495
+712
+15% +$176K 0.89% 51
2023
Q3
$1.18M Buy
4,783
+179
+4% +$49K 0.79% 49
2023
Q2
$1.4M Buy
4,604
+4,579
+18,316% +$1.27M 0.97% 43
2023
Q1
$6.59K Hold
25
﹤0.01% 123
2022
Q4
$6K Buy
+25
New +$5.6K ﹤0.01% 108

Other funds holding HCA

Robbins Farley's HCA Position: Q1 2026 in Review

Robbins Farley reduced its HCA Healthcare (HCA) stake by 0.25% in Q1 2026, selling an estimated $5.03K and leaving 4,007 shares worth $1.9M. The position accounts for 0.84% of the portfolio, ranked #46.

Robbins Farley first reported a position in HCA in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.25M in Q2 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Robbins Farley held 4,007 shares of HCA Healthcare worth $1.9M as of Q1 2026.
  • Robbins Farley sold 10 HCA Healthcare shares in Q1 2026, an estimated $5.03K.
  • HCA Healthcare made up 0.84% of Robbins Farley's portfolio in Q1 2026, its #46 holding.
  • Robbins Farley first reported a position in HCA Healthcare in Q4 2022 and has held it in 14 quarters since.
  • Robbins Farley's HCA Healthcare position peaked at $2.25M in Q2 2025.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Robbins Farley's 13F filing for Q1 2026, filed 17 Apr 2026.